Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Optical coherence tomography guided retreatment of photodynamic therapy.

    Krebs I, Binder S, Stolba U, Schmid K, Glittenberg C, Brannath W, Goll A.

    Br J Ophthalmol. 2005 Sep;89(9):1184-7.PMID: 16113378 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):245-54. Epub 2007 Aug 3.PMID: 17674020 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    5.

    Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT.

    van Velthoven ME, de Smet MD, Schlingemann RO, Magnani M, Verbraak FD.

    Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1119-23. Epub 2006 Mar 8.PMID: 16523305 [PubMed - indexed for MEDLINE]Related articles

    6.

    Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.

    Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA.

    Retina. 2007 Sep;27(7):825-31.PMID: 17891004 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

    Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.

    Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):339-44. Epub 2007 Sep 6.PMID: 17805556 [PubMed - indexed for MEDLINE]Related articles

    8.

    An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

    Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M.

    Am J Ophthalmol. 2007 Apr;143(4):566-83.PMID: 17386270 [PubMed - indexed for MEDLINE]Related articles

    9.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    10.

    Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization.

    Costa RA, Farah ME, Cardillo JA, Calucci D, Williams GA.

    Retina. 2003 Apr;23(2):159-65.PMID: 12707593 [PubMed - indexed for MEDLINE]Related articles

    11.

    Optical coherence tomography to monitor photodynamic therapy in pathological myopia.

    García-Layana A, Salinas-Alamán A, Maldonado MJ, Sainz-Gómez C, Fernández-Hortelano A.

    Br J Ophthalmol. 2006 May;90(5):555-8. Epub 2006 Feb 7.PMID: 16464970 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.

    Piermarocchi S, Sartore M, Lo Giudice G, Maritan V, Midena E, Segato T.

    Arch Ophthalmol. 2008 Oct;126(10):1367-74.PMID: 18852414 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy.

    Krebs I, Binder S, Stolba U, Glittenberg C, Brannath W, Goll A.

    Am J Ophthalmol. 2005 Sep;140(3):416-25.PMID: 16139000 [PubMed - indexed for MEDLINE]Related articles

    14.

    Optical coherence tomography in neovascular age related macular degeneration compared to fluorescein angiography and visual acuity.

    Henschel A, Spital G, Lommatzsch A, Pauleikhoff D.

    Eur J Ophthalmol. 2009 Sep-Oct;19(5):831-5.PMID: 19787605 [PubMed - indexed for MEDLINE]Related articles

    15.

    Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization.

    Rogers AH, Martidis A, Greenberg PB, Puliafito CA.

    Am J Ophthalmol. 2002 Oct;134(4):566-76.PMID: 12383814 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

    Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    18.

    Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

    Kaiser PK, Blodi BA, Shapiro H, Acharya NR; MARINA Study Group.

    Ophthalmology. 2007 Oct;114(10):1868-75. Epub 2007 Jul 12.PMID: 17628683 [PubMed - indexed for MEDLINE]Related articles

    19.

    Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration.

    Salinas-Alamán A, García-Layana A, Maldonado MJ, Sainz-Gómez C, Alvárez-Vidal A.

    Am J Ophthalmol. 2005 Jul;140(1):23-8.PMID: 15922284 [PubMed - indexed for MEDLINE]Related articles

    20.

    Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

    Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS.

    Ophthalmology. 2006 Nov;113(11):2002.e1-12. Epub 2006 Oct 5.PMID: 17027972 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data